We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,677 hedge funds and large institutions have $365B invested in Johnson & Johnson in 2022 Q1 according to their latest regulatory filings, with 169 funds opening new positions, 1,680 increasing their positions, 1,450 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 169 | Existing positions closed: 90

42% more call options, than puts

Call options by funds: $3.29B | Put options by funds: $2.33B

35% more funds holding in top 10

Funds holding in top 10: 395532 (+137)

18% more capital invested

Capital invested by funds: $309B → $365B (+$55.8B)

16% more repeat investments, than reductions

Existing positions increased: 1,680 | Existing positions reduced: 1,450

1% more funds holding

Funds holding: 3,6453,677 (+32)

0.14% more ownership

Funds ownership: 69.01%69.15% (+0.14%)

Holders
3,677
Holders Change
+32
Holders Change %
+0.88%
% of All Funds
57.99%
Holding in Top 10
532
Holding in Top 10 Change
+137
Holding in Top 10 Change %
+34.68%
% of All Funds
8.39%
New
169
Increased
1,680
Reduced
1,450
Closed
90
Calls
$3.29B
Puts
$2.33B
Net Calls
+$968M
Net Calls Change
+$95.4M
Name Holding Trade Value Shares
Change
Change in
Stake
MP
1401
McDonald Partners
Ohio
$5.06M +$4.86M +28,565 New
MMHP
1402
Murphy Middleton Hinkle & Parker
Georgia
$5.06M +$424K +2,490 +10%
PTC
1403
Philadelphia Trust Company
Pennsylvania
$5.05M +$6.3K +37 +0.1%
Squarepoint
1404
Squarepoint
New York
$5.05M -$40.2M -236,425 -89%
MPIA
1405
Mountain Pacific Investment Advisers
Idaho
$5.05M -$76.6K -450 -2%
PMG
1406
ProVise Management Group
Florida
$5.04M +$437K +2,570 +10%
JWCA
1407
J.W. Coons Advisors
Ohio
$5.04M +$919K +5,402 +23%
AAS
1408
Ameritas Advisory Services
Nebraska
$5.03M +$226K +1,326 +5%
BWM
1409
Baystate Wealth Management
Massachusetts
$5.03M -$44.4K -261 -0.9%
PFS
1410
Physicians Financial Services
North Carolina
$5.02M -$17.4K -102 -0.4%
BCA
1411
Bray Capital Advisors
Florida
$5.01M +$21.4K +126 +0.4%
BSB
1412
Bangor Savings Bank
Maine
$5M +$140K +821 +3%
VHAM
1413
Van Hulzen Asset Management
California
$4.98M -$75K -441 -2%
DPIM
1414
Duff & Phelps Investment Management
Illinois
$4.98M +$44.2K +260 +0.9%
KFGK
1415
Keystone Financial Group (Kentucky)
Kentucky
$4.97M +$79.1K +465 +2%
TI
1416
tru Independence
Oregon
$4.96M +$281K +1,654 +6%
CGL
1417
Clarius Group LLC
Washington
$4.96M
SIM
1418
Studio Investment Management
Illinois
$4.95M -$270K -1,586 -5%
GA
1419
GFS Advisors
Texas
$4.95M -$3.2M -18,800 -40%
SIMM
1420
Stillwater Investment Management (Minnesota)
Minnesota
$4.95M +$24.2K +142 +0.5%
WAC
1421
William Allan Corp
Colorado
$4.94M +$86.6K +509 +2%
ACM
1422
AlphaStar Capital Management
North Carolina
$4.94M -$249K -1,462 -5%
BOTW
1423
Bank of the West
California
$4.94M +$239K +1,407 +5%
FC
1424
Fusion Capital
South Carolina
$4.93M +$344K +2,019 +8%
FPS
1425
Fieldpoint Private Securities
Connecticut
$4.92M +$476K +2,798 +11%

JNJ Hedge Fund Activity: Q1 2022 in Review

3,677 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q1 2022, worth a combined $365B — up 18% from $309B a quarter earlier.

Buyers outnumbered sellers: 169 funds opened new JNJ positions and 90 closed out — a net gain of 79 holders — while 1,680 added to existing stakes and 1,450 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $1.06B. The largest seller was Fundsmith LLP, cutting an estimated $1.19B.

  • 3,677 institutional investors held Johnson & Johnson (JNJ) as of Q1 2022, up from 3,645 in Q4 2021.
  • Funds reported $365B of Johnson & Johnson stock for Q1 2022, up 18% quarter-over-quarter.
  • 169 funds opened new Johnson & Johnson positions in Q1 2022 and 90 closed out, a net change of +79 holders.
  • The largest Johnson & Johnson buyer in Q1 2022 was T. Rowe Price Associates, an estimated $1.06B added.
  • The largest Johnson & Johnson seller in Q1 2022 was Fundsmith LLP, an estimated $1.19B sold.

Based on aggregated 13F filings for Q1 2022.